KEAP1 and synovial sarcoma: Additionally, KEAP1 protein levels, an inhibitor of NRF2 that sequesters NRF2 in the cytosol preventing it from entering the nucleus and acting as a transcription factor (27), significantly decreased in the LSGs of SS-patients (p = 0.033, Figures 14G,H).